annual EBIT:
-$98.85M-$25.87M(-35.45%)Summary
- As of today (June 17, 2025), JANX annual earnings before interest & taxes is -$98.85 million, with the most recent change of -$25.87 million (-35.45%) on December 31, 2024.
- During the last 3 years, JANX annual EBIT has fallen by -$65.92 million (-200.18%).
- JANX annual EBIT is now -2521.24% below its all-time high of -$3.77 million, reached on December 31, 2019.
Performance
JANX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
-$34.90M-$5.88M(-20.24%)Summary
- As of today (June 17, 2025), JANX quarterly earnings before interest & taxes is -$34.90 million, with the most recent change of -$5.88 million (-20.24%) on March 31, 2025.
- Over the past year, JANX quarterly EBIT has dropped by -$14.74 million (-73.09%).
- JANX quarterly EBIT is now -2678.42% below its all-time high of -$1.26 million, reached on September 30, 2020.
Performance
JANX quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$113.58M-$14.74M(-14.91%)Summary
- As of today (June 17, 2025), JANX TTM earnings before interest & taxes is -$113.58 million, with the most recent change of -$14.74 million (-14.91%) on March 31, 2025.
- Over the past year, JANX TTM EBIT has dropped by -$40.72 million (-55.89%).
- JANX TTM EBIT is now -8530.93% below its all-time high of -$1.32 million, reached on March 31, 2020.
Performance
JANX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
JANX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -35.5% | -73.1% | -55.9% |
| 3 y3 years | -200.2% | -157.7% | -157.1% |
| 5 y5 years | -2521.2% | -2551.8% | -8530.9% |
JANX EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -200.2% | at low | -157.7% | +2.6% | -157.1% | at low |
| 5 y | 5-year | -2521.2% | at low | -2678.4% | +2.6% | -8530.9% | at low |
| alltime | all time | -2521.2% | at low | -2678.4% | +2.6% | -8530.9% | at low |
JANX EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$34.90M(+20.2%) | -$113.58M(+14.9%) |
| Dec 2024 | -$98.85M(+35.4%) | -$29.02M(-19.0%) | -$98.85M(+15.0%) |
| Sep 2024 | - | -$35.84M(+159.3%) | -$85.96M(+30.4%) |
| Jun 2024 | - | -$13.82M(-31.4%) | -$65.93M(-9.5%) |
| Mar 2024 | - | -$20.16M(+24.9%) | -$72.86M(-0.2%) |
| Dec 2023 | -$72.98M(+8.8%) | -$16.14M(+2.0%) | -$72.98M(-2.8%) |
| Sep 2023 | - | -$15.81M(-23.8%) | -$75.11M(-2.9%) |
| Jun 2023 | - | -$20.75M(+2.3%) | -$77.32M(+4.7%) |
| Mar 2023 | - | -$20.28M(+11.0%) | -$73.83M(+10.0%) |
| Dec 2022 | -$67.09M | -$18.27M(+1.4%) | -$67.09M(+7.7%) |
| Sep 2022 | - | -$18.02M(+4.4%) | -$62.31M(+12.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$17.26M(+27.5%) | -$55.20M(+24.9%) |
| Mar 2022 | - | -$13.54M(+0.4%) | -$44.19M(+34.2%) |
| Dec 2021 | -$32.93M(+400.6%) | -$13.49M(+23.7%) | -$32.93M(+56.1%) |
| Sep 2021 | - | -$10.90M(+74.4%) | -$21.09M(+84.3%) |
| Jun 2021 | - | -$6.25M(+173.7%) | -$11.45M(+51.7%) |
| Mar 2021 | - | -$2.28M(+38.0%) | -$7.55M(+14.7%) |
| Dec 2020 | -$6.58M(+74.4%) | -$1.66M(+31.8%) | -$6.58M(+33.6%) |
| Sep 2020 | - | -$1.26M(-46.6%) | -$4.92M(+34.3%) |
| Jun 2020 | - | -$2.35M(+78.6%) | -$3.67M(+178.6%) |
| Mar 2020 | - | -$1.32M | -$1.32M |
| Dec 2019 | -$3.77M | - | - |
FAQ
- What is Janux Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Janux Therapeutics?
- What is Janux Therapeutics annual EBIT year-on-year change?
- What is Janux Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Janux Therapeutics?
- What is Janux Therapeutics quarterly EBIT year-on-year change?
- What is Janux Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Janux Therapeutics?
- What is Janux Therapeutics TTM EBIT year-on-year change?
What is Janux Therapeutics annual earnings before interest & taxes?
The current annual EBIT of JANX is -$98.85M
What is the all time high annual EBIT for Janux Therapeutics?
Janux Therapeutics all-time high annual earnings before interest & taxes is -$3.77M
What is Janux Therapeutics annual EBIT year-on-year change?
Over the past year, JANX annual earnings before interest & taxes has changed by -$25.87M (-35.45%)
What is Janux Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of JANX is -$34.90M
What is the all time high quarterly EBIT for Janux Therapeutics?
Janux Therapeutics all-time high quarterly earnings before interest & taxes is -$1.26M
What is Janux Therapeutics quarterly EBIT year-on-year change?
Over the past year, JANX quarterly earnings before interest & taxes has changed by -$14.74M (-73.09%)
What is Janux Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of JANX is -$113.58M
What is the all time high TTM EBIT for Janux Therapeutics?
Janux Therapeutics all-time high TTM earnings before interest & taxes is -$1.32M
What is Janux Therapeutics TTM EBIT year-on-year change?
Over the past year, JANX TTM earnings before interest & taxes has changed by -$40.72M (-55.89%)